These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 12643993)

  • 1. Can primaquine therapy for vivax malaria be improved?
    Baird JK; Rieckmann KH
    Trends Parasitol; 2003 Mar; 19(3):115-20. PubMed ID: 12643993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Two imported and relapsed of Plasmodium vivax malaria cases and primaquine prophylaxis].
    Hatipoğlu M; Ulçay A; Turhan V; Karagöz E; Erdem H; Acar A; Oncül O; Görenek L
    Turkiye Parazitol Derg; 2014 Jun; 38(2):120-3. PubMed ID: 25016120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imported tertian malaria resistant to primaquine.
    Na DJ; Han JD; Cha DY; Song IK; Choi HW; Chung EA; Park CW; Choi JS
    Korean J Intern Med; 1999 Jul; 14(2):86-9. PubMed ID: 10461431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of relapsing Plasmodium vivax malaria.
    Chu CS; White NJ
    Expert Rev Anti Infect Ther; 2016 Oct; 14(10):885-900. PubMed ID: 27530139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [How much primaquine is needed to eradicate Plasmodium vivax hypnozoites?].
    Muñoz J; Velasco M; Alonso D; Valls ME; Corachán M; Gascón J
    Enferm Infecc Microbiol Clin; 2006 Jan; 24(1):29-30. PubMed ID: 16537060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primaquine treatment and relapse in Plasmodium vivax malaria.
    Rishikesh K; Saravu K
    Pathog Glob Health; 2016; 110(1):1-8. PubMed ID: 27077309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primaquine treatment for Plasmodium vivax--an essential tool for malaria control and elimination in Papua New Guinea.
    Betuela I; Robinson LJ; Hetzel MW; Laman M; Siba PM; Bassat Q; Mueller I
    P N G Med J; 2014; 57(1-4):68-74. PubMed ID: 26930890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimating the Proportion of
    Commons RJ; Simpson JA; Watson J; White NJ; Price RN
    Am J Trop Med Hyg; 2020 Sep; 103(3):1094-1099. PubMed ID: 32524950
    [No Abstract]   [Full Text] [Related]  

  • 9. A pilot randomized controlled trial to compare the effectiveness of two 14-day primaquine regimens for the radical cure of vivax malaria in South India.
    Saravu K; Tellapragada C; Kulavalli S; Xavier W; Umakanth S; Brahmarouphu G; Srinivas NK; Channabasavaiah JP; Bava A; Saadi AV; Guddattu V; Satyamoorthy K; Bhat K
    Malar J; 2018 Sep; 17(1):321. PubMed ID: 30176897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving the radical cure of vivax malaria (IMPROV): a study protocol for a multicentre randomised, placebo-controlled comparison of short and long course primaquine regimens.
    IMPROV Study Group
    BMC Infect Dis; 2015 Dec; 15():558. PubMed ID: 26643116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High Efficacy of Primaquine Treatment for Plasmodium vivax in Western Thailand.
    Longley RJ; Sripoorote P; Chobson P; Saeseu T; Sukasem C; Phuanukoonnon S; Nguitragool W; Mueller I; Sattabongkot J
    Am J Trop Med Hyg; 2016 Nov; 95(5):1086-1089. PubMed ID: 27601524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Impaired Cytochrome P450 2D6 Activity Genotype and Phenotype With Therapeutic Efficacy of Primaquine Treatment for Latent Plasmodium vivax Malaria.
    Baird JK; Louisa M; Noviyanti R; Ekawati L; Elyazar I; Subekti D; Chand K; Gayatri A; Instiaty ; Soebianto S; Crenna-Darusallam C; Djoko D; Hasto BD; Meriyenes D; Wesche D; Nelwan EJ; Sutanto I; Sudoyo H; Setiabudy R
    JAMA Netw Open; 2018 Aug; 1(4):e181449. PubMed ID: 30646129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic efficacy of chloroquine and chloroquine plus primaquine for the treatment of Plasmodium vivax in Ethiopia.
    Yeshiwondim AK; Tekle AH; Dengela DO; Yohannes AM; Teklehaimanot A
    Acta Trop; 2010 Feb; 113(2):105-13. PubMed ID: 19835832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primaquine ineligibility in anti-relapse therapy of Plasmodium vivax malaria: the problem of G6PD deficiency and cytochrome P-450 2D6 polymorphisms.
    Baird JK; Battle KE; Howes RE
    Malar J; 2018 Jan; 17(1):42. PubMed ID: 29357870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic Assessment of Chloroquine-Primaquine Combined Regimen in Adult Cohort of Plasmodium vivax Malaria from Primary Care Centres in Southwestern India.
    Saravu K; Kumar R; Ashok H; Kundapura P; Kamath V; Kamath A; Mukhopadhyay C
    PLoS One; 2016; 11(6):e0157666. PubMed ID: 27315280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Several Plasmodium vivax relapses after correct primaquine treatment in a patient with impaired cytochrome P450 2D6 function.
    Martin Ramírez A; Lombardia González C; Soler Maniega T; Gutierrez Liarte Á; Domingo García D; Lanza Suárez M; Bernal Fernández MJ; Rubio JM
    Malar J; 2020 Jul; 19(1):259. PubMed ID: 32680522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of antimalarial activity and toxicity of a new primaquine prodrug.
    Davanço MG; Aguiar AC; Dos Santos LA; Padilha EC; Campos ML; de Andrade CR; da Fonseca LM; Dos Santos JL; Chin CM; Krettli AU; Peccinini RG
    PLoS One; 2014; 9(8):e105217. PubMed ID: 25133630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short report: primaquine-tolerant Plasmodium vivax in an Italian traveler from Guatemala.
    Signorini L; Matteelli A; Castelnuovo F; Castelli F; Oladeji O; Carosi G
    Am J Trop Med Hyg; 1996 Nov; 55(5):472-3. PubMed ID: 8940974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactive medical case. A chilly fever.
    Redig AJ; Vaidya A; Price C; Katz JT; Maguire JH
    N Engl J Med; 2014 Oct; 371(16):e24. PubMed ID: 25317891
    [No Abstract]   [Full Text] [Related]  

  • 20. Recurrent Plasmodium vivax malaria due to dose-dependent primaquine resistance: a case report.
    Kristensen KL; Dragsted UB
    Scand J Infect Dis; 2014 Jan; 46(1):63-5. PubMed ID: 23957539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.